CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,577,126
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-27 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +41,600 | 41,600 | ||
| 2017-02-16 | Grais Linda S Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2017-02-16 | MITCHELL DANIEL J Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2017-02-16 | Selby Brian L. VP, Finance | Grant or award · Stock Option (right to buy) | +23,000 | 23,000 | ||
| 2017-02-16 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2017-02-16 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2017-02-16 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +42,000 | 42,000 | ||
| 2017-02-16 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2017-02-16 | Hove Anders D Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2017-02-16 | Keuer Thomas A Chief Operating Officer | Grant or award · Stock Option (right to buy) | +25,200 | 25,200 | ||
| 2016-10-18 | Keuer Thomas A Chief Operating Officer | Sale | −483 | $2.45 | $1K | 14,900 |
| 2016-09-20 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Sale | −1,972 | $2.89 | $6K | 42,638 |
| 2016-09-20 | Keuer Thomas A Chief Operating Officer | Sale | −714 | $2.89 | $2K | 15,383 |
| 2016-09-20 | Ozeroff Christopher David S.V.P., General Counsel | Sale | −1,185 | $2.89 | $3K | 18,400 |
| 2016-09-19 | Selby Brian L. VP, Finance | Sale | −476 | $2.91 | $1K | 2,550 |
| 2016-06-09 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +27,200 | 27,200 | ||
| 2016-06-09 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Grant or award · Stock Option (right to buy) | +55,400 | 55,400 | ||
| 2016-06-09 | Keuer Thomas A Chief Operating Officer | Grant or award · Stock Option (right to buy) | +15,600 | 15,600 | ||
| 2016-06-09 | Keuer Thomas A Chief Operating Officer | Grant or award · Stock Option (right to buy) | +31,700 | 31,700 | ||
| 2016-06-09 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award · Stock Option (right to buy) | +14,800 | 14,800 |
Page 22 of 24 · 473 trades